Huang X et al., 2024-01-12: Meta-analysis of six RCTs (265 patients) in distributive shock finding no mortality difference but shorter ventilation and hospital stay with methylene blue.
The use of MB may not reduce mortality in patients with distributive shock, but may shorten the duration of mechanical ventilation, ICU LOS and hospital LOS.
Huang X et al., 2024-01-12: Meta-analysis of six RCTs (265 patients) in distributive shock finding no mortality difference but shorter ventilation and hospital stay with methylene blue. C5 (mixed result). Study type: meta-analysis of RCTs, 6 trials, N=265, search to 19 April 2023; Nanchang University, China; PROSPERO CRD42023415938. Mortality OR 0.59 (95% CI 0.32 to 1.06). Comparator: placebo. Competing interests: none declared. Bearing PARTLY because the mortality endpoint was null while length-of-stay endpoints favoured methylene blue. BMJ Open 2024;14:e080065. Study type: review.
